AISAP Cardio vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AISAP Cardio

by Aisap

AI-CVD

by HeartLung Corporation

AI Verdict

AISAP Cardio is designed for real-time, point-of-care cardiac diagnostic assessments using ultrasound, providing immediate insights at the bedside. In contrast, AI-CVD focuses on opportunistic screening for cardiovascular risks by analyzing existing CT scans, identifying potential issues without requiring new imaging procedures. While both leverage AI for cardiac disease detection, their distinct input modalities and clinical workflows make them complementary rather than direct competitors.

Choose AISAP Cardio if…

Choose AISAP Cardio if your priority is rapid, real-time cardiac diagnostic assessment at the point of care. This tool is ideal for clinicians needing immediate, AI-powered interpretation of bedside ultrasound exams to quickly detect structural heart disease and heart failure, providing comprehensive measurements and reports during patient encounters.

View AISAP Cardio →

Choose AI-CVD if…

Choose AI-CVD if you aim to opportunistically screen for cardiovascular and multisystem diseases using existing CT scans without additional imaging or patient burden. This platform is best suited for leveraging previously acquired chest and abdominal CTs to identify hidden risks like coronary artery calcium, valvular calcifications, and abnormal cardiac chamber volumes, integrating seamlessly into existing radiology workflows.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AISAP Cardio	AI-CVD
Pricing	Not publicly available	Contact for pricing
Deployment	Cloud-based SaaS platform	Cloud
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio empowers clinicians with basic scanning skills to accurately diagnose common cardiac conditions at the bedside within minutes, making advanced diagnostics more accessible to a wider range of healthcare professionals. While AI-CVD offers opportunistic screening without workflow disruption, AISAP Cardio actively enhances the usability of a diagnostic procedure for immediate, point-of-care decision-making.

Clinical Value

AISAP Cardio

AISAP Cardio provides rapid, comprehensive cardiac diagnostic assessments, including LVEF and valvular pathologies, enabling early detection of structural heart disease and heart failure directly at the bedside. This immediate, detailed diagnostic information has a direct impact on acute patient management and care pathways. While AI-CVD offers broad opportunistic screening for various risks, AISAP Cardio's real-time diagnostic capability for specific conditions provides a more immediate clinical impact.

Pricing & Value

Tie

Neither AISAP Cardio nor AI-CVD publicly disclose their pricing information, making a direct comparison on cost impossible. Both tools, however, have indications of Medicare reimbursement pathways for their respective services, which adds significant value for healthcare providers.

Enterprise Readiness

AISAP Cardio

Both tools are FDA-cleared and cloud-based SaaS platforms. However, AISAP Cardio explicitly highlights its 'vendor-agnostic and scalable solution' and 'Integration with existing clinical workflows, EHR/EMR, and PACS,' along with being HIPAA-compliant and ISO-certified. Its reported use in leading U.S. health systems further demonstrates its robust enterprise readiness.

Innovation

AI-CVD

While AISAP Cardio innovates by democratizing advanced cardiac POCUS diagnostics at the point of care, AI-CVD presents a more novel paradigm shift by opportunistically extracting comprehensive, multi-system health insights from *already existing* CT scans. This approach identifies hidden risks without requiring additional imaging or workflow disruption, leveraging existing data in a highly efficient and non-invasive manner.

Support & Docs

Tie

Both companies provide general resources such as blogs, case studies, publications, and news, and offer contact information for inquiries. However, neither tool explicitly details dedicated customer support channels, service level agreements, or comprehensive technical documentation beyond these general resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AISAP Cardio	AI-CVD
Name	AISAP Cardio	AI-CVD
Company	Aisap	HeartLung Corporation
Description	FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside.	FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.
Categories	Cardiology AI	Cardiology AI
Specialties	Cardiology, Emergency Medicine, Radiology	Cardiology, Pulmonology, Radiology
Key Features (Cardiac)	AI-powered interpretation for early cardiac disease detection; Comprehensive cardiac ultrasound software package; Automated generation of analyses, interpretations, and reports; Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis); Measurement of Left Ventricle Ejection Fraction (LVEF); Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter.	Automated CT-derived anatomical and density-based measurements; Opportunistic screening from existing chest and abdominal CT scans; Coronary Artery Calcium (CAC) scoring; Aortic wall, aortic valve, and mitral valve calcium analysis; Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle); Epicardial fat volumetry; Aorta and pulmonary artery sizing.

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and AI-CVD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What type of imaging data does each tool utilize?

AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform, meaning it processes ultrasound data for its cardiac assessments. In contrast, AI-CVD is a quantitative imaging platform that performs opportunistic screening using existing chest and abdominal CT scans.

What are the primary clinical applications for each tool?

AISAP Cardio provides rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside, enabling early detection of structural heart disease and heart failure. AI-CVD focuses on opportunistic screening for cardiovascular and multisystem diseases using existing CT scans to enable early detection of hidden health risks.

What specific cardiac measurements or analyses do these tools provide?

AISAP Cardio assesses valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), measures Left Ventricle Ejection Fraction (LVEF), and provides measurements of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. AI-CVD offers coronary artery calcium (CAC) scoring, analysis of aortic wall, aortic valve, and mitral valve calcium, cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), epicardial fat volumetry, and aorta and pulmonary artery sizing.

How do these tools integrate into existing clinical workflows?

AISAP Cardio is designed for integration with existing clinical workflows, EHR/EMR, and PACS systems. AI-CVD performs opportunistic screening from existing CT scans, explicitly stating that it requires no additional imaging, radiation, contrast, or workflow disruption.

Do these tools require additional imaging or patient procedures?

AISAP Cardio is a POCUS software platform, which works with ultrasound imaging performed at the point of care. AI-CVD leverages existing CT scans for its analysis, and explicitly states that it does not require additional imaging, radiation, contrast, or workflow disruption.